MedTrace Logo

Treatment of Patients With Acute Sinusitis

NCT00930488 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6777

Last updated 2012-11-20

No results posted yet for this study

Summary

For each patient, an initial visit and at least one follow-up visit at the end of treatment should be documented by the treating physician in the case report form.

Conditions

  • Acute Bacterial Sinusitis

Interventions

DRUG

Avelox (Moxifloxacin, BAY12-8039)

Patients with a diagnosis of acute bacterial sinusitis who take moxifloxacin

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Austria
  • Bahrain
  • China
  • Egypt
  • France
  • Germany
  • Indonesia
  • Jordan
  • Kuwait
  • Lebanon
  • Malaysia
  • Netherlands
  • Pakistan
  • Philippines
  • Romania
  • Saudi Arabia
  • Singapore
  • United Arab Emirates
  • Yemen

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00930488 on ClinicalTrials.gov